This controlled trial investigates the efficacy of Groups 4 Health to improve the mental health of people of higher weight through psychotherapy and behaviour change, decreasing feelings of loneliness and weight stigma through social networks.

The Aligned Study is an investigator-initiated, randomized controlled trial of pharmacogenomic-guided therapy versus standard care for people with depression who require initiation or change in antidepressant therapy.

The primary objective of this project is to investigate psychological, cognitive and physiological changes associated with a single session of psychedelic drug exposure with psilocybin or 3,4-methylenedioxymethamphetamine (MDMA) in a group setting.

The project has been designed for the collection of outcome and safety data on the use of novel interventional pharmacotherapy approaches. The AIPPAP Research Registry is designed to capture real-world clinical data on the use of ketamine, MDMA, and psilocybin.

This study explores the rural health workforce. In particular what leads to the uptake of rural health care by medical doctors including general practitioners, and whatsupports continued medical practice in rural areas.

This project aims to analyze the circulating miRNA pre-operation of the TKA and knee tissue mRNA post primary TKA.